The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development.
about
Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, MalawiDiversity of T cell epitopes in Plasmodium falciparum circumsporozoite protein likely due to protein-protein interactions.Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regionsCross-fertilization among fields: a seminal event in the progress of biomedical research.Multiple antigen peptide vaccines against Plasmodium falciparum malariaPoly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.Immunology of human malaria. A cellular perspective.An update on candidate malaria vaccines.Variation and polymorphism in parasite phenotype--implications for the selection of potential intervention strategies.Nature and nurture: overcoming constraints on immunity.Molecular basis of host-parasite relationship: towards the definition of protective antigens.Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.Developments with anti-malarial vaccines.Genetic analysis of host-parasite coevolution in human malariaStrain specificity of bovine Theileria parva-specific cytotoxic T cells is determined by the phenotype of the restricting class I MHC.Progress toward a malaria vaccine.Identification of a major human immunodeficiency virus-1 reverse transcriptase epitope recognized by mouse CD4+ T lymphocytes.The hope but challenge for developing a vaccine that might control malaria.Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children.An antigen specific to the liver stage of rodent malaria recognized by a monoclonal antibody.Natural amino acid polymorphisms of the circumsporozoite protein of Plasmodium falciparum abrogate specific human CD4+ T cell responsiveness.Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization.Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses
P2860
Q24617275-7E94F1E8-97A2-4E06-ABD3-E9931F2544B8Q30430387-D4971508-C5C1-4697-9210-2B3F84F873F1Q33957574-BBC62A3E-02D4-41D7-8984-47FFDA90805CQ34181335-91F85E9A-66CD-47AB-A01A-EED325AB5B29Q34290800-AFAE2BD2-E68B-492C-9EF0-B3BA54742EE6Q34416103-DFAE6FC9-FC59-4E2B-B4E5-89A945AA259DQ35500705-CCA142E5-5B75-4F37-A9BA-244CD9F21EFFQ35773738-FDA3864E-2471-4853-8670-3604FB144A64Q36668538-1073FEBC-C00B-4194-A3CD-231A886C1167Q37482822-47A24850-1637-45C3-8D90-FE617E64C173Q38627927-0E3C623A-1823-4865-9B71-F251C9DE6E83Q38635546-C43CCEA6-14E1-48D9-97A5-5420628BD9CCQ38715956-816226ED-5433-45C2-A1A4-A3F3DF702378Q38715960-003625E2-92F9-49EB-982D-4A442DFF6702Q38749505-3404D12B-1FE1-4859-B400-4D2BA418D308Q38890556-BEF9E6D0-9B62-4932-9033-686481F21A50Q40066878-473A69B4-A204-4BDE-9776-5C1A8DE88D84Q40067251-73B9B386-3A99-4474-85D7-EF58569BBADBQ40428303-D77A00D4-F7D3-47DB-8464-225D5C7F8D88Q40715913-576B1373-F7DB-446F-9C2B-91DE86F78C48Q40840674-7C636870-6BBC-4561-8C51-DA31101BB5E6Q41756366-25ADDCD0-75B4-4110-A2E7-2B0B4896C9D8Q44145507-103572C3-5BBE-492D-97E8-0E9EBDBB44AFQ45859779-544AF625-92E7-4BC2-89AB-2DD6F51D80DEQ47640667-5893781F-BFB8-4210-AC85-AE95F98A65B2Q47863358-E10881EC-EEB2-42FE-9721-06BA8BE063B0Q47883115-2E7DB66B-26BC-45AD-885A-5989C5C3E0D8Q48008772-7663BA95-7031-4333-BCCF-1C0A66E53FA1Q48030704-2107F074-3D5F-47A1-AFA9-385C5A26DEF6Q57607867-35E8C104-ED6A-48A2-AD7C-D47BFBC2E563
P2860
The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
The T cell response to the mal ...... proach to vaccine development.
@en
The T cell response to the mal ...... proach to vaccine development.
@nl
type
label
The T cell response to the mal ...... proach to vaccine development.
@en
The T cell response to the mal ...... proach to vaccine development.
@nl
prefLabel
The T cell response to the mal ...... proach to vaccine development.
@en
The T cell response to the mal ...... proach to vaccine development.
@nl
P1476
The T cell response to the mal ...... proach to vaccine development.
@en
P2093
Berzofsky JA
P304
P356
10.1146/ANNUREV.IY.06.040188.003311
P577
1988-01-01T00:00:00Z